Related Experiment Videos
Fibronectin and lymphocyte blast transformation
R Tarnavschi1, R Bălună, I Belaşcu
1Department of Immunology, Babes Institute, Bucharest, Romania.
Summary
Human plasma fibronectin (Fn) enhances mitogen action in leukocyte cultures. Increased Fn concentration on day four correlates with maximum blast transformation, suggesting Fn influences immune cell activation.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Fibronectin (Fn) is a key extracellular matrix protein involved in cell adhesion and migration.
- Leukocyte activation by mitogens like phytohemagglutinin (PHA) is crucial for immune responses.
- The role of fibronectin in modulating mitogen-induced leukocyte activation requires further elucidation.
Purpose of the Study:
- To investigate the effect of purified human plasma fibronectin (Fn) on phytohemagglutinin (PHA)-stimulated human peripheral blood leukocyte cultures.
- To determine the temporal relationship between fibronectin concentration and blast transformation in leukocyte cultures.
Main Methods:
- Human peripheral blood leukocytes from 22 healthy donors were cultured with or without PHA and varying doses of Fn.
- Fibronectin concentration in culture supernatants was measured daily for six days.
- Blast transformation, an indicator of mitogen-induced cell proliferation, was assessed.
Main Results:
- Addition of Fn to PHA-stimulated leukocyte cultures significantly enhanced mitogen action.
- A significant increase in Fn concentration was observed in supernatants of cultures incubated with both Fn and PHA, peaking on day four.
- Maximum blast transformation coincided with the peak Fn concentration on day four.
Conclusions:
- Fibronectin, potentially synthesized by activated macrophages, is released into culture supernatants, with maximal levels observed on day four.
- These findings suggest a role for fibronectin in enhancing mitogen-induced blast transformation in leukocyte cultures.
- Fibronectin may play a significant role in modulating immune cell activation processes.